In a previous JD Supra article, I wrote about the Sixth Circuit Court’s initial decision, which upheld class certification for the matter despite GM’s challenges to Article III and predominance, in the case of Speerly v....more
In 2022, over 500 plaintiffs filed a case alleging that Merck Sharp & Dohme Corp., a drug manufacturing company, failed to provide adequate warnings that one of their drugs increased the risk of atypical femoral fractures....more
An August 2024 decision by a panel of the U.S. Sixth Circuit in Speerly v. General Motors, which underscores key developments in the law governing class certification, Article III standing, and the treatment of manifest...more
12/23/2024
/ Article III ,
Automotive Industry ,
Class Action ,
Class Certification ,
Class Members ,
En Banc Review ,
General Motors ,
Injury-in-Fact ,
Manufacturers ,
Manufacturing Defects ,
Motor Vehicles ,
Product Defects
Inhance Technologies, a Texas-based plastic and chemical transformation company, went head-to-head with the Environmental Protection Agency (EPA) before the U.S. Fifth Circuit Court of Appeals earlier this year. The Court’s...more
As of May 2022, Monsanto, the company that developed the allegedly cancer-causing weed killer Roundup, has settled more than 100,000 lawsuits, and paid nearly $11 billion in settlements. Despite this massive number, 30,000...more
3/29/2024
/ Cancer ,
Chemicals ,
Consumer Product Companies ,
Environmental Protection Agency (EPA) ,
Failure To Warn ,
FIFRA ,
Hazardous Substances ,
Manufacturers ,
Marketing ,
Misbranding ,
Pesticides ,
Product Labels ,
Settlement Agreements ,
Warning Labels